South Africa vs Ukraine: Life science patents granted, by technology
South Africa
2 patents
in 2023
Ukraine
1 patents
in 2023
South Africa rank
52nd
Ukraine rank
55th
Life science patents granted, by technology over time
- South Africa
- Ukraine
How they compare
South Africa currently reports 2 patents against 1 patents in Ukraine, a difference of 1 patents.
That makes South Africa's figure about 2.0 times Ukraine's.
The two have swapped places 6 times across 31 shared years of data; in 1993 it was South Africa ahead.
South Africa ranks 52nd and Ukraine ranks 55th of 65 countries.
Across the 4 decades both report, South Africa averaged higher in 3 and Ukraine in 1.
Head to head by decade
| Decade | South Africa | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 578.43 patents | 22 patents | 556.43 patents | South Africa |
| 2000s | 712.2 patents | 361.2 patents | 351 patents | South Africa |
| 2010s | 243.7 patents | 363.2 patents | 119.5 patents | Ukraine |
| 2020s | 8.25 patents | 2.25 patents | 6 patents | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, South Africa or Ukraine?
- South Africa, at 2 patents against 1 patents in Ukraine as of 2023.
- What is the difference in life science patents granted, by technology between South Africa and Ukraine?
- 1 patents, with South Africa ahead.
- How many years of comparable data are there for South Africa and Ukraine?
- 31 years are reported by both, from 1993 to 2023.
- How do South Africa and Ukraine rank globally for life science patents granted, by technology?
- South Africa ranks 52nd and Ukraine ranks 55th of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) β processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.